Yan Jie, Wang Yuan, Shao Shi-He, Mao Ya-Fei, Li Hua-Wen, Luo Yi-Hui
Department of Medical Microbiology and Parasitology, Medical College, Zhejiang University, Hangzhou 310031, Zhejiang Province, China.
World J Gastroenterol. 2004 Apr 15;10(8):1183-90. doi: 10.3748/wjg.v10.i8.1183.
To construct a prokaryotic expression system of a Helicobacter pylori (H pylori) cagA gene fragment and establish enzyme-linked immunosorbent assays (ELISA) for detecting CagA and its antibody, so as to understand the manner in which the infection of CagA-expressing H pylori (CagA(+) H pylori) isolates cause diseases.
H pylori strains in gastric biopsy specimens from 156 patients with positive results in rapid urease test were isolated. PCR was used to detect the frequency of cagA gene in the 109 H pylori isolates and to amplify a 2 148-bp fragment (cagA1) of cagA gene from a clinical strain Y06. A prokaryotic expression system of cagA1 gene was constructed, and the expression of the target recombinant protein (rCagA1) was examined by SDS-PAGE. Western blotting and immunodiffusion assay were employed to determine the immunoreactivity and antigenicity of rCagA1, respectively. Two ELISAs were established to detect CagA expression in 109 H pylori isolates and the presence of CagA antibody in the corresponding patients' sera, and the correlations between infection with CagA(+) H pylori and gastritis as well as peptic ulcer were analyzed.
Of all the clinical specimens obtained, 80.8% (126/156) were found to have H pylori isolates and 97.2% of the isolates (106/109) were positive for cagA gene. In comparison with the reported data, the cloned cagA1 fragment possessed 94.83% and 93.30% homologies with the nucleotide and putative amino acid sequences, respectively. The output of rCagA1 produced by the constructed recombinant prokaryotic expression system was approximately 30% of the total bacterial protein. rCagA1 was able to bind to the commercial antibody against the whole-cells of H pylori and to induce the immunized rabbits to produce antibody with an immunodiffusion titer of 1:4. A proportion as high as 92.6% of the H pylori isolates (101/109) expressed CagA and 88.1% of the patients' serum samples (96/109) were CagA antibody-positive. The percentage of CagA(+) H pylori strains (97.9%) isolated from the biopsy specimens of peptic ulcer appeared to be higher than that from gastritis (88.5%), but the difference was not statistically significant (chi (2)=3.48, P>0.05).
rCagA1 produced by the prokaryotic expression system constructed in this study possesses good immunoreactivity and antigenicity, and the established ELISAs can be used to detect CagA of H pylori and its antibody. H pylori isolates show high frequencies of cagA gene and CagA expression, but the infections by CagA(+) H pylori strains are not the most decisive factors to cause gastric diseases.
构建幽门螺杆菌(H pylori)cagA基因片段的原核表达系统,建立检测CagA及其抗体的酶联免疫吸附测定(ELISA),以了解表达CagA的幽门螺杆菌(CagA(+) H pylori)菌株的感染致病方式。
从156例快速尿素酶试验结果阳性的胃活检标本中分离幽门螺杆菌菌株。采用聚合酶链反应(PCR)检测109株幽门螺杆菌中cagA基因的频率,并从临床菌株Y06中扩增出cagA基因的一个2148 bp片段(cagA1)。构建cagA1基因的原核表达系统,通过十二烷基硫酸钠-聚丙烯酰胺凝胶电泳(SDS-PAGE)检测目标重组蛋白(rCagA1)的表达。分别采用蛋白质印迹法和免疫扩散试验确定rCagA1的免疫反应性和抗原性。建立两种ELISA检测109株幽门螺杆菌中CagA的表达及相应患者血清中CagA抗体的存在情况,并分析CagA(+) H pylori感染与胃炎及消化性溃疡之间的相关性。
在所有获得的临床标本中,80.8%(126/156)发现有幽门螺杆菌菌株,97.2%的菌株(106/109)cagA基因呈阳性。与已报道数据相比,克隆的cagA1片段与核苷酸序列和推测的氨基酸序列的同源性分别为94.83%和93.30%。构建的重组原核表达系统产生的rCagA1产量约占细菌总蛋白的30%。rCagA1能够与抗幽门螺杆菌全菌的商业抗体结合,并诱导免疫兔产生免疫扩散效价为1:4的抗体。高达92.6%的幽门螺杆菌菌株(101/109)表达CagA,88.1%的患者血清样本(96/109)CagA抗体呈阳性。从消化性溃疡活检标本中分离出的CagA(+) H pylori菌株的百分比(97.9%)似乎高于胃炎标本中的(88.5%),但差异无统计学意义(χ² = 3.48,P > 0.05)。
本研究构建的原核表达系统产生的rCagA1具有良好的免疫反应性和抗原性,所建立的ELISA可用于检测幽门螺杆菌的CagA及其抗体。幽门螺杆菌菌株中cagA基因和CagA表达的频率较高,但CagA(+) H pylori菌株的感染并非导致胃部疾病的最决定性因素。